GLAXOSMITHKLINE ILLACLARI

GlaxoSmithKline Ilaclari is a Manufacturer.

Company Introduction:

GlaxoSmithKline Ilaclari is the Turkish subsidiary of GlaxoSmithKline (GSK), a leading global healthcare company. Operating as a fully integrated pharmaceutical entity in Turkey, it is involved in the manufacturing, marketing, and distribution of a broad portfolio of pharmaceutical products, vaccines, and consumer healthcare items. The company plays a significant role in providing essential medicines and healthcare solutions to the Turkish market and contributes to local production capacity. Its operations encompass research and development, local production facilities, and a comprehensive sales and distribution network across the country.

GlaxoSmithKline Ilac Sanayi ve Ticaret A.S. (GSK Turkey) primarily focuses on pharmaceutical products and vaccines. Please note that product availability can vary and portfolios are dynamic. GSK's consumer healthcare products are now part of Haleon.

Key product categories and examples of products typically produced or sold by GSK Turkey include:

Respiratory Products:

Seretide (for asthma and COPD)

Relvar Ellipta (for asthma and COPD)

Nucala (for severe eosinophilic asthma)

Ventolin (salbutamol for asthma)

Vaccines:

Shingrix (for shingles)

Fluarix/Flulaval (influenza vaccine)

Boostrix (Tdap vaccine)

Infanrix Hexa (DTaP-IPV-Hib-HepB vaccine)

Rotarix (rotavirus vaccine)

Bexsero (meningococcal B vaccine)

HIV Products (through ViiV Healthcare, a company majority-owned by GSK):

Tivicay (dolutegravir)

Triumeq (dolutegravir/abacavir/lamivudine)

Dovato (dolutegravir/lamivudine)

Immunology Products:

Benlysta (for systemic lupus erythematosus)

Oncology Products:

Jemperli (dostarlimab)

Zejula (niraparib)